{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:07:42Z","timestamp":1791824862489,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.neuropharm.2013.03.007","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T17:50:06Z","timestamp":1364493006000},"page":"27-36","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Central functional response to the novel peptide cannabinoid, hemopressin"],"prefix":"10.1016","volume":"71","author":[{"given":"Garron T.","family":"Dodd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy A.","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan J.","family":"Hodkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Luckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.03.007_bib1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0028-3908(02)00364-7","article-title":"Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain","volume":"44","author":"Allen","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0306-4522(94)90471-5","article-title":"Synaptic input and output of parvalbumin-immunoreactive neurons in the neostriatum of the rat","volume":"62","author":"Bennett","year":"1994","journal-title":"Neuroscience"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2013.03.007_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2826.2008.01676.x","article-title":"Endogenous cannabinoids: structure and metabolism","volume":"20","author":"Bisogno","year":"2008","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib4","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0022-3565(24)36967-8","article-title":"Regional differences in cannabinoid receptor\/G-protein coupling in rat brain","volume":"282","author":"Breivogel","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib5","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1021\/pr060690r","article-title":"Optimization of neuropeptide extraction from the mouse hypothalamus","volume":"6","author":"Che","year":"2007","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib6","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archgenpsychiatry.2007.37","article-title":"Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study","volume":"65","author":"Deakin","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib8","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s00125-008-1048-2","article-title":"The endocannabinoid system in obesity and type 2 diabetes","volume":"51","author":"Di Marzo","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib9","doi-asserted-by":"crossref","first-page":"12567","DOI":"10.1073\/pnas.1109567108","article-title":"Endocannabinoids: an appetite for fat","volume":"108","author":"Di Marzo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","author":"Di Marzo","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-3-642-17214-4_4","article-title":"Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes","author":"Di Marzo","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib12","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1523\/JNEUROSCI.5455-09.2010","article-title":"The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice","volume":"30","author":"Dodd","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.neuroscience.2009.07.022","article-title":"Central cannabinoid signaling mediating food intake: a pharmacological-challenge magnetic resonance imaging and functional histology study in rat","volume":"163","author":"Dodd","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1471-4159.2010.06671.x","article-title":"Functional magnetic resonance imaging and c-Fos mapping in rats following a glucoprivic dose of 2-deoxy-D-glucose","volume":"113","author":"Dodd","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2012.01.007","article-title":"Involvement of descending serotonergic and noradrenergic pathways in CB(1) receptor-mediated antinociception","author":"Dogrul","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0024-3205(97)00690-5","article-title":"Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors","volume":"61","author":"Gatley","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib17","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1096\/fj.09-132142","article-title":"Novel endogenous peptide agonists of cannabinoid receptors","volume":"23","author":"Gomes","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib18","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002","article-title":"A\u00a0peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding","volume":"22","author":"Gomez","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/npp.2011.260","article-title":"Modulation of fronto-cortical activity by modafinil: a functional imaging and fos study in the rat","volume":"37","author":"Gozzi","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biopsych.2004.10.032","article-title":"Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents","volume":"57","author":"Griebel","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1744-8069-5-35","article-title":"Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain","volume":"5","author":"Guasti","year":"2009","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuroscience.2004.01.037","article-title":"Chronic food restriction increases D-1 dopamine receptor agonist-induced phosphorylation of extracellular signal-regulated kinase 1\/2 and cyclic AMP response element-binding protein in caudate\u2013putamen and nucleus accumbens","volume":"125","author":"Haberny","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2011.07.031","article-title":"Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain","volume":"1412","author":"Hama","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pbb.2011.09.004","article-title":"Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception","volume":"100","author":"Hama","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib25","doi-asserted-by":"crossref","first-page":"14828","DOI":"10.1523\/JNEUROSCI.1526-09.2009","article-title":"PACAP neurons in the hypothalamic ventromedial nucleus are targets of central leptin signaling","volume":"29","author":"Hawke","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/76572","article-title":"Spikes versus BOLD: what does neuroimaging tell us about neuronal activity?","volume":"3","author":"Heeger","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib27","doi-asserted-by":"crossref","first-page":"20588","DOI":"10.1073\/pnas.0706980105","article-title":"Hemopressin is an inverse agonist of CB1 cannabinoid receptors","volume":"104","author":"Heimann","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in\u00a0vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0306-4522(01)00509-7","article-title":"Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain","volume":"109","author":"Hermann","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib30","doi-asserted-by":"crossref","first-page":"E693","DOI":"10.1208\/aapsj080479","article-title":"Endocannabinoid mechanisms of pain modulation","volume":"8","author":"Hohmann","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.physbeh.2005.08.066","article-title":"Corticostriatal\u2013hypothalamic circuitry and food motivation: integration of energy, action and reward","volume":"86","author":"Kelley","year":"2005","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0166-4328(97)00054-5","article-title":"Feeding induced by blockade of AMPA and kainate receptors within the ventral striatum: a microinfusion mapping study","volume":"89","author":"Kelley","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/09540260902782810","article-title":"Cannabinoids and appetite: food craving and food pleasure","volume":"21","author":"Kirkham","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","article-title":"Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol","volume":"136","author":"Kirkham","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib36","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2826.2008.01734.x","article-title":"Measurement of immediate\u2013early gene activation \u2013 c-fos and beyond","volume":"20","author":"Kovacs","year":"2008","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tips.2008.10.001","article-title":"Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain?","volume":"30","author":"Kunos","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/mrm.10366","article-title":"Characterization of effects of mean arterial blood pressure induced by cocaine and cocaine methiodide on BOLD signals in rat brain","volume":"49","author":"Luo","year":"2003","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.wnr.0000198945.62326.ba","article-title":"Pituitary adenylate cyclase-activating polypeptide neurons of the ventromedial hypothalamus project to the midbrain central gray","volume":"17","author":"Maekawa","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0006-8993(98)01368-7","article-title":"Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections","volume":"822","author":"Martin","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib42","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/0024-3205(95)00195-C","article-title":"An examination of the central sites of action of cannabinoid-induced antinociception in the rat","volume":"56","author":"Martin","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.neuroimage.2011.06.049","article-title":"Mirtazapine antagonises the subjective, hormonal and neuronal effects of m-chlorophenylpiperazine (mCPP) infusion: a pharmacological-challenge fMRI (phMRI) study","volume":"58","author":"McKie","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-8993(01)02605-1","article-title":"CB1 receptor mediated analgesia from the Nucleus Reticularis Gigantocellularis pars alpha is activated in an animal model of neuropathic pain","volume":"908","author":"Monhemius","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.brainresrev.2005.07.001","article-title":"About being BOLD","volume":"50","author":"Nair","year":"2005","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000081069","article-title":"Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model","volume":"73","author":"Nakazato","year":"2005","journal-title":"Pharmacology"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib47","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.2337\/db08-0161","article-title":"Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats","volume":"57","author":"Nogueiras","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib48","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1111\/j.1476-5381.2011.01478.x","article-title":"The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone","volume":"165","author":"Olango","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib49","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/3-540-26573-2_1","article-title":"Pharmacological actions of cannabinoids","author":"Pertwee","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib51","first-page":"51","article-title":"FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels","volume":"11","author":"Petrosino","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2006.08.011","article-title":"Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats","volume":"52","author":"Petrosino","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.nurt.2009.08.002","article-title":"Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside","volume":"6","author":"Rahn","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib54","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/nbm.978","article-title":"Continuous noninvasive monitoring of transcutaneous blood gases for a stable and persistent BOLD contrast in fMRI studies in the rat","volume":"18","author":"Ramos-Cabrer","year":"2005","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib55","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1074\/jbc.M212030200","article-title":"Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme","volume":"278","author":"Rioli","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib56","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.neuroimage.2006.04.214","article-title":"A\u00a0stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI","volume":"32","author":"Schwarz","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib57","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2826.2005.01330.x","article-title":"Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: effects on feeding behaviour","volume":"17","author":"Scott","year":"2005","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib58","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.neuropharm.2004.08.008","article-title":"Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716","volume":"47","author":"Singh","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib59","doi-asserted-by":"crossref","first-page":"e2202","DOI":"10.1371\/journal.pone.0002202","article-title":"Feeding induced by cannabinoids is mediated independently of the melanocortin system","volume":"3","author":"Sinnayah","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib60","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.neuroimage.2006.01.046","article-title":"Functional magnetic resonance imaging and c-Fos mapping in rats following an anorectic dose of m-chlorophenylpiperazine","volume":"31","author":"Stark","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib61","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00213-003-1579-7","article-title":"Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs","volume":"171","author":"Sumner","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-007-0745-8","article-title":"A\u00a0comparison of the effects of the CB(1) receptor antagonist SR141716A, pre-feeding and changed palatability on the microstructure of ingestive behaviour","volume":"193","author":"Thornton-Jones","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib63","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00213-004-2047-8","article-title":"The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food","volume":"179","author":"Thornton-Jones","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib64","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/3-540-26573-2_4","article-title":"Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice","author":"Valverde","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib65","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib66","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0026-895X(24)23200-4","article-title":"Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in\u00a0vitro","volume":"57","author":"Vaughan","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib67","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/3-540-26573-2_17","article-title":"Cannabinoid mechanisms of pain suppression","author":"Walker","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.03.007_bib68","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","article-title":"Endocannabinoid signaling in the brain","volume":"296","author":"Wilson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.03.007_bib69","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1476-5381.2009.00184.x","article-title":"Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative pain","volume":"157","author":"Zhu","year":"2009","journal-title":"Br. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813001032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813001032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T02:31:13Z","timestamp":1745980273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813001032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":69,"alternative-id":["S0028390813001032"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.03.007","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}